Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank sector big daddy Mesoblast ...

Tumor microenvironment (TME) plays a pivotal role in malignant progression and metastatization in several tumors, including ...

May 9, 2025 — Researchers have developed two unique energy-efficient and cost-effective systems that use urea found in urine and wastewater to generate hydrogen. The unique systems reveal new ...

Stem cell injections, platelet rich plasma and ivermectin do big business despite dubious or no evidence supporting their use in rheumatology. However, far from being a recent development, this type ...

Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown function of immune cells in the bone marrow.

Mesenchymal precursor cells plus hyaluronic acid significantly reduced chronic low back pain due to degenerative disc disease.

The promise of mesenchymal stem cells (MSCs) to heal heart disease could be around the corner thanks to a new delivery method tested by regenerative medicine company Cynata Therapeutics Ltd.

Puerto Vallarta, Mexico - R3 Stem Cell, a global leader in regenerative therapies, has announced the opening of its newest ...

Abu Dhabi Stem Cells Center and Yas Clinic Khalifa Hospital announced groundbreaking findings on innovative treatments for ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See why MESO stock is a buy.

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug manufacturing.